1. Hinescu ME, Gherghiceanu M, Mandache E et al. Interstitial Cajal-like cells (ICLC) in human atrial myocardium J. Cell. Mol. Med. 2005;9(4):972-5. doi:10.1111/j1582-4934.2006.tb00306.x.
2. Cretoiu D, Hummel E, Zimmermann H et al. Human cardiac telocytes: 3D imaging by FIB-SEM tomography. 2014 J. Cell. Mol. Med. 2014;18(11):2157-64. doi:10.1111/jcmm.12468.
3. Gherghiceanu M, Popescu LM. Cardiac telocytes — their junctions and functional implications. Cell Tissue Res. 2012;348:265-79. doi:10.1007/s00441-012-1333-8.
4. Gherghiceanu M, Popescu LM. Cardiomyocyte precursors and telocytes in epicardial stem cell niche. J Cell Mol Med. 2010;14:871-7. doi:10.1111/j.1582-4934.2010.01060.x.
5. Kostin S, Popescu LM. A distinct type of cell in myocardium: interstitial Cajal-like cells (ICLCs). J. Cell. Mol. Med. 2009;13(2):296-309. doi:10.1111/j.1582-4934.2008.00668.x.
6. Mitrofanova LB, Orshanskaya VS, Ho SY, Platonov PG. Histological evidence of inflammatory reaction associated with fibrosis in the atrial and ventricular walls in a case-control study of patients with history of atrial fibrillation. Europace. 2016;18(suppl 4): iv156-iv162 doi: 10.1093/europace/euw361.
7. Isakov SV, Baghdasaryan AU, Gordeev ML. Operation MAZE IV: The technique of a modified version. Cardiology and cardiovascular surgery. 2017;10(5):12-15. doi:10.17116/kardio201710512-15.
8. Richter M., Kostin S. The failing human heart is characterized by decreased numbers of telocytes as result of apoptosis and altered extracellular matrix composition J. Cell. Mol. Med. 2015;19(11):2597-606. doi:10.1111/jcmm.12664.
9. Zhao B, Chen S, Liu J et al. Cardiac telocytes were decreased during myocardial infarction and their therapeutic effects for ischaemic heart in rat. J Cell Mol Med. 2013;17(1):123-33. doi:10.1111/j.1582-4934.2012.01655.x.
10. Mandache E, Gherghiceanu M, Macarie C et al. Telocytes in human isolated atrial amyloidosis: ultrastructural remodelling. J Cel Moll Med.2010;14:2739-47. doi:10.1111/j.1582-4934.2010.01200.x.
11. Manetti M, Rosa I, Messerini L et al. A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis. J Cell Mol Med. 2014;18:253-62. doi:10.1111/jcmm112228.
12. Hinescu ME, Gherghiceanu M, Mandache E et al. Interstitial Cajal-like cells (ICLC) in atrial myocardium: ultrastructural and immunohistochemical characterization. J Cell Mol Med. 2006;10(1):243-57 doi:10.1111/j.1582-4934.2006.tb00306.x.
13. Liu JJ, Shen XT, Zheng X et al. Distribution of telocytes in the rat heart. J Clin Rehabil Tiss Eng Res. 2011;15:3546-8. doi:10.1007/s00441-012-1333-8.
14. Kostin S. Cardiac telocytes in normal and diseased hearts. Semin Cell Dev Biol. 2016;55:22-30. doi:10.1016/j.semcdb.2016.02.023.
15. Bani D, Formigli L, Gherghiceanu M et al. Telocytes as supporting cells for myocardial tissue organization in developing and adult heart. J Cell Mol Med. 2010;14(10):2531-8. doi:10.1111/j.1582-4934.2010.01119.x.
16. Mitrofanova LB, Gorshkov AN, Konovalov PV et al. Telocytes in human sino-atrial node. Morphological evidence of pacemaker cell activity and the ability to conduct an electrical impulse. Russian Journal of Cardiology. 2017;22(9):42-9. doi:10.15829/1560-4071-2017-9-42-49.
17. Popescu LM, Gherghiceanu M, Hinescu ME, et al. Insights into the interstitium of ventricular myocardium: interstitial Cajal-like cells (ICLC). J. Cell. Mol. Med. 2006;10(2):429-58. doi:10.1111/j.1582-4934.2006.tb00410.x.
18. Yang J, Li Y, Xue F, et al. Exosomes derived from cardiac telocytes exert positive effects on endothelial cells. Am J Transl Res. 2017;9(12):5375-87.
19. Banciu DD, Banciu A, Radu BM. Electrophysiological Features of Telocytes. In: Wang X., Cretoiu D. (eds) Telocytes. Advances in Experimental Medicine and Biology, vol 913. Springer, Singapore, 2016. doi:10.1007/978-981-10-1061-3_19.
20. Sheng J, ShimW, Lu J, et al. Electrophysiology of human cardiac atrial and ventricular telocytes. J. Cell. Mol. Med. 2014;18(2):355-62. doi:10.1111/jcmm.12240.
